Free Trial

Verrica Pharmaceuticals (VRCA) SEC Filings & 10K Form

Verrica Pharmaceuticals logo
$0.66 -0.04 (-5.56%)
(As of 03:03 PM ET)

Recent Verrica Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/09/2024
5:22 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
12/09/2024
4:17 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
4:18 PM
Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:55 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/21/2024
3:53 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:06 PM
Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:08 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:32 AM
Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
7:59 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:02 PM
Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
8:03 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:04 PM
Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:11 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:17 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:15 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:37 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:15 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM
Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:16 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:50 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
3:45 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:35 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:31 PM
Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:17 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
2:08 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
6:56 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:07 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2024
5:10 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:11 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:12 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
5:13 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:51 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
2:55 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
2:47 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:18 PM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
6:45 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:31 PM
Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/13/2024
7:01 AM
Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
6:46 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
6:35 AM
Verrica Pharmaceuticals (Filer)
Form DEFA14A
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin
04/19/2024
6:40 AM
Verrica Pharmaceuticals (Filer)
Form ARS
04/19/2024
6:30 AM
Verrica Pharmaceuticals (Filer)
Form DEF 14A
03/19/2024
3:31 PM
Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:31 PM
Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
7:05 AM
Verrica Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/29/2024
6:45 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:47 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
8:10 AM
Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
7:01 AM
Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:27 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
6:21 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:52 PM
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRCA) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners